VRX-LDLR

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVRX-LDLR
Drug Alias Namefamilial hypercholesterolemia therapy (VIRxSYS)VRX-LDLR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirxsys Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirxsys Corp
Active IndicationsN/A
Inactive IndicationsHyperlipoproteinemia Type II

Other Information

ATC CodeN/A
Related LinksN/A